BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 29903786)

  • 1. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.
    Ruzicka DJ; Imai K; Takahashi K; Naito T
    BMJ Open; 2018 Jun; 8(6):e019985. PubMed ID: 29903786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study.
    Ruzicka DJ; Imai K; Takahashi K; Naito T
    J Infect Chemother; 2019 Feb; 25(2):89-95. PubMed ID: 30396821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities and co-medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan.
    Naito T; Suzuki M; Fukushima S; Yuda M; Fukui N; Tsukamoto S; Fujibayashi K; Goto-Hirano K; Kuwatsuru R
    HIV Med; 2022 May; 23(5):485-493. PubMed ID: 34821006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
    Kong AM; Pozen A; Anastos K; Kelvin EA; Nash D
    AIDS Patient Care STDS; 2019 Mar; 33(3):93-103. PubMed ID: 30844304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
    Moore HN; Mao L; Oramasionwu CU
    AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of comedications and potential drug-drug interactions in people living with HIV in China.
    Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
    J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity and comedication burden among people living with HIV in the United States.
    Paudel M; Prajapati G; Buysman EK; Goswami S; Mao J; McNiff K; Kumar P
    Curr Med Res Opin; 2022 Aug; 38(8):1443-1450. PubMed ID: 35757905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
    Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
    Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey.
    Tinggaard M; David KP; Gerstoft J; Hansen AE; Kirk O; Lebech AM; Lindhardt BØ; Rose MV; Ryom L; Weis N; Benfield T
    HIV Med; 2023 Jan; 24(1):46-54. PubMed ID: 35521975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study.
    Nanditha NGA; Paiero A; Tafessu HM; St-Jean M; McLinden T; Justice AC; Kopec J; Montaner JSG; Hogg RS; Lima VD
    BMJ Open; 2021 Jan; 11(1):e041734. PubMed ID: 33419911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016.
    Ruzicka DJ; Tetsuka J; Fujimoto G; Kanto T
    BMC Infect Dis; 2018 May; 18(1):237. PubMed ID: 29793436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database.
    Ruzicka DJ; Kuroishi N; Oshima N; Sakuma R; Naito T
    BMC Infect Dis; 2019 Jun; 19(1):505. PubMed ID: 31182050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age on care pathways of people living with HIV followed up in hospital.
    Jacomet C; Berland P; Guiguet M; Simon A; Rey D; Arvieux C; Pugliese P; Gerbaud L
    AIDS Care; 2017 Jan; 29(1):105-111. PubMed ID: 27334840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.
    Fontela C; Castilla J; Juanbeltz R; Martínez-Baz I; Rivero M; O'Leary A; Larrea N; San Miguel R
    Postgrad Med; 2018 Apr; 130(3):317-324. PubMed ID: 29486621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.
    Okoli C; Schwenk A; Radford M; Myland M; Taylor S; Darley A; Barnes J; Fox A; Grimson F; Reeves I; Munshi S; Croucher A; Boxall N; Benn P; Paice A; van Wyk J; Khoo S
    HIV Med; 2020 Sep; 21(8):471-480. PubMed ID: 32671950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for progressing to severe COVID-19 among people living with HIV in Japan: A hospital claims database study.
    Kanazawa A; Yan Y; Yuda M; Fukui N; Saita M; Mori H; Naito T
    J Infect Chemother; 2024 Jan; 30(1):40-47. PubMed ID: 37708941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
    Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G
    BMC Geriatr; 2018 Apr; 18(1):99. PubMed ID: 29678160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
    Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
    Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study.
    Serrão R; Piñero C; Velez J; Coutinho D; Maltez F; Lino S; Sarmento E Castro R; Tavares AP; Pacheco P; Lopes MJ; Mansinho K; Miranda AC; Neves I; Correia de Abreu R; Almeida J; Pássaro L
    Int J Infect Dis; 2019 Feb; 79():94-100. PubMed ID: 30529370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.